Exploring the renewed potential of estramustine phosphate in treating hormone-refractory prostate cancer through dual-mechanism action and clinical evidence.
Explore how LH-RH analogues work as a biochemical 'off-switch' in advanced prostate cancer treatment through clinical evaluation and research findings.